X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 39,067 | -51,766 | -101,167 | -82,037 | -79,732 |
| Depreciation Amortization | 256 | 62 | 419 | 357 | 253 |
| Accounts payable and accrued liabilities | -944 | 4 | 1,234 | 426 | -2,815 |
| Other Working Capital | 3,138 | 2,090 | 344 | 5,702 | 2,162 |
| Other Operating Activity | -105,391 | 16,013 | 2,658 | 6,787 | 32,195 |
| Operating Cash Flow | $-63,874 | $-33,597 | $-96,512 | $-68,765 | $-47,937 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 104,807 | -59 | -60 | -25 | N/A |
| Net Acquisitions | N/A | N/A | N/A | N/A | -17 |
| Purchase Of Investment | -13,267 | -10,263 | -16,823 | -11,025 | -4,876 |
| Sale Of Investment | 7,000 | 5,000 | 2,000 | 1,000 | N/A |
| Purchase Sale Intangibles | -7,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -7,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $91,540 | $-5,322 | $-14,883 | $-10,050 | $-4,893 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 20,000 | N/A | 22,500 | 22,500 | -381 |
| Debt Repayment | N/A | N/A | -2,064 | -2,064 | -1,300 |
| Common Stock Issued | 159 | N/A | 68,711 | 68,614 | 68,895 |
| Other Financing Activity | 0 | 0 | -631 | -631 | 0 |
| Financing Cash Flow | $20,159 | $N/A | $88,516 | $88,419 | $67,214 |
| Exchange Rate Effect | -77 | -59 | 99 | -28 | 44 |
| Beginning Cash Position | 100,248 | 100,248 | 123,028 | 123,028 | 123,028 |
| End Cash Position | 147,996 | 61,270 | 100,248 | 132,604 | 137,456 |
| Net Cash Flow | $47,748 | $-38,978 | $-22,780 | $9,576 | $14,428 |
| Free Cash Flow | |||||
| Operating Cash Flow | -63,874 | -33,597 | -96,512 | -68,765 | -47,937 |
| Capital Expenditure | -193 | -59 | -60 | -25 | N/A |
| Free Cash Flow | -64,067 | -33,656 | -96,572 | -68,790 | -47,937 |